ADVFN - ニュース

S&P 500

5,277.51

0.80%

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

該当コードがありません。

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/03	14 : 34	PR Newswire (US)	State Grid Zhenjiang Power Supply Company Enhances Real-time Estimation Accuracy for Low-voltage Distributed Photovoltaics
2024/06/03	14 : 31	Alliance News	Alliance News UK - start of day
2024/06/03	14 : 30	GlobeNewswire Inc.	Nombre de droits de vote au 31 mai 2024	LSE:0RCQ	Nicox Sa
2024/06/03	14 : 30	GlobeNewswire Inc.	BGHL (GBP): NAV(s)	LSE:BGHS	Boussard & Gavaudan Holding Limited
2024/06/03	14 : 30	GlobeNewswire Inc.	Transgene - First Patient Enrolled in Phase II Part of Randomized Phase I/II Trial Evaluating Lead Cancer Vaccine TG4050 in Head and Neck Cancer	LSE:0OCQ	Transgene Sa
2024/06/03	14 : 30	GlobeNewswire Inc.	Number of voting rights as of May 31, 2024	TG:NXOA	Nicox SA
2024/06/03	14 : 30	GlobeNewswire Inc.	Nombre de droits de vote au 31 mai 2024	TG:NXOA	Nicox SA
2024/06/03	14 : 30	GlobeNewswire Inc.	BW Energy: Fixed Income Investor Meetings	TG:6BW	BW Energy Limited
2024/06/03	14 : 30	GlobeNewswire Inc.	Vallourec : André Lacerda est nommé Directeur Amérique du Sud (Activités Tubes)
2024/06/03	14 : 30	GlobeNewswire Inc.	Vallourec: Andre Lacerda Appointed Senior Vice President of South America (Tubes Activities)	EU:VK	Vallourec
2024/06/03	14 : 30	GlobeNewswire Inc.	Transgene - First Patient Enrolled in Phase II Part of Randomized Phase I/II Trial Evaluating Lead Cancer Vaccine TG4050 in Head and Neck Cancer	EU:TNG	Transgene SA
2024/06/03	14 : 30	GlobeNewswire Inc.	Number of voting rights as of May 31, 2024	EU:ALCOX	Nicox SA
2024/06/03	14 : 30	GlobeNewswire Inc.	Transgene – Premier patient inclus dans la partie Phase II de l’étude randomisée de Phase I/II de son actif phare TG4050, un vaccin thérapeutique individualisé évalué dans les cancers de la tête et du cou	LSE:0OCQ	Transgene Sa
2024/06/03	14 : 30	GlobeNewswire Inc.	Transgene - First Patient Enrolled in Phase II Part of Randomized Phase I/II Trial Evaluating Lead Cancer Vaccine TG4050 in Head and Neck Cancer	EU:TNG	Transgene SA
2024/06/03	14 : 30	GlobeNewswire Inc.	BGHL (GBP): NAV(s)	EU:BGHS	Boussard and Gavaudan Holding
2024/06/03	14 : 30	GlobeNewswire Inc.	Vallourec: Andre Lacerda Appointed Senior Vice President of South America (Tubes Activities)
2024/06/03	14 : 30	GlobeNewswire Inc.	Transgene – Premier patient inclus dans la partie Phase II de l’étude randomisée de Phase I/II de son actif phare TG4050, un vaccin thérapeutique individualisé évalué dans les cancers de la tête et du cou	EU:TNG	Transgene SA
2024/06/03	14 : 30	GlobeNewswire Inc.	Nombre de droits de vote au 31 mai 2024	EU:ALCOX	Nicox SA
2024/06/03	14 : 30	GlobeNewswire Inc.	Number of voting rights as of May 31, 2024	LSE:0RCQ	Nicox Sa
2024/06/03	14 : 30	GlobeNewswire Inc.	BGHL (EUR): NAV(s)	EU:BGHL	Boussard And Gavaudan Holding Limited
2024/06/03	14 : 30	GlobeNewswire Inc.	BGHL (EUR): NAV(s)	LSE:BGHL	Boussard & Gavaudan Holding Limited
2024/06/03	14 : 25	GlobeNewswire Inc.	BW Energy: Appraisal confirms material Hibiscus field reserve increase	TG:6BW	BW Energy Limited
2024/06/03	14 : 06	Cointelegraph	Why Ethereum ETF day one inflow won’t be like Bitcoin — Fireblocks MD	COIN:FLOWUSD	Flow
2024/06/03	14 : 06	Cointelegraph	Why Ethereum ETF day one inflow won’t be like Bitcoin — Fireblocks MD	COIN:BTCUSD	Bitcoin
2024/06/03	14 : 05	Crypto Briefing	Space ID set to unlock 18% of token supply this month	COIN:ARBUSD	Arbitrum
2024/06/03	14 : 01	PR Newswire (US)	Formosa Laboratories Completes the Acquisition of Synchem to Expand North American CDMO Footprint
2024/06/03	14 : 00	GlobeNewswire Inc.	ALK presents positive phase 3 paediatric trial data offering new hope for children with respiratory allergies	TG:4AJ0	ALK Abello AS
2024/06/03	14 : 00	GlobeNewswire Inc.	Ontex finalizes the divestment of its business in Pakistan	EU:ONTEX	Ontex Group NV
2024/06/03	14 : 00	Business Wire	Avanzanite Bioscience Reports AKANTIOR® Received Positive CHMP Opinion and Announces Corporate Expansion Into 26 European Countries
2024/06/03	14 : 00	GlobeNewswire Inc.	Corbion reports the progress of its € 20 million share buyback program 27 May – 31 May 2024	EU:CRBN	Corbion N.V.